Sara Luder of Slaughter and May looks at the implications for the UK of the decision taken by Shire plc to introduce a new non-UK-tax-resident holding company
Sara Luder of Slaughter and May looks at the implications for the UK of the decision taken by Shire plc to introduce a new non-UK-tax-resident holding company
For many tax advisers who advise UK multinationals the announcement made by Shire (the UK-tax-resident holding company of a global specialty biopharmaceutical group) on 15 April did not come as a huge surprise. There cannot be many UK multinationals that have not at least considered briefly the possibility of implementing such a transaction even if only to dismiss it as 'too hard' or 'not yet'. The Shire transaction will therefore be followed closely by UK plc.
Ever since...
If you or your firm subscribes to Taxjournal.com, please click the login box below:
If you do not subscribe but are a registered user, please enter your details in the following boxes:
Sara Luder of Slaughter and May looks at the implications for the UK of the decision taken by Shire plc to introduce a new non-UK-tax-resident holding company
Sara Luder of Slaughter and May looks at the implications for the UK of the decision taken by Shire plc to introduce a new non-UK-tax-resident holding company
For many tax advisers who advise UK multinationals the announcement made by Shire (the UK-tax-resident holding company of a global specialty biopharmaceutical group) on 15 April did not come as a huge surprise. There cannot be many UK multinationals that have not at least considered briefly the possibility of implementing such a transaction even if only to dismiss it as 'too hard' or 'not yet'. The Shire transaction will therefore be followed closely by UK plc.
Ever since...
If you or your firm subscribes to Taxjournal.com, please click the login box below:
If you do not subscribe but are a registered user, please enter your details in the following boxes:
